Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.985
-0.135 (-6.37%)
Apr 25, 2025, 11:22 AM EDT - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $274.49 million as of April 25, 2025. Its market cap has increased by 19.46% in one year.
Market Cap
274.49M
Enterprise Value
156.48M
1-Year Change
19.46%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $274.49M, a decrease of -36.95%. That is a compound annual growth rate of -10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 293.16M | 46.94% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 777.43B |
| UnitedHealth Group | 377.37B |
| Johnson & Johnson | 370.37B |
| AbbVie | 325.09B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.34B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |